Celsius (NASDAQ:CELH) Price Target Raised to $61.00

Key Points

• Morgan Stanley raised Celsius' price target from $56.00 to $61.00, while maintaining an "equal weight" rating, indicating a potential downside of 2.99% from its current price.
• Other analysts have varied ratings and price targets for Celsius, with Mizuho setting a target of $90.00 and Roth Capital adjusting theirs to $52.00, contributing to a consensus rating of "Moderate Buy."
• Celsius reported a quarterly earnings per share of $0.47, significantly beating estimates and experiencing an 83.9% increase in revenue compared to the same quarter last year.

Celsius (NASDAQ:CELH - Free Report) had its price target increased by Morgan Stanley from $56.00 to $61.00 in a research report sent to investors on Tuesday morning, Marketbeat reports. Morgan Stanley currently has an equal weight rating on the stock.

A number of other analysts also recently commented on CELH. Wells Fargo & Company boosted their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. Citigroup reissued a "buy" rating on shares of Celsius in a report on Sunday, August 31st. Stephens reissued an "overweight" rating on shares of Celsius in a report on Monday, August 11th. Roth Capital reissued a "buy" rating and issued a $52.00 price target (up from $46.00) on shares of Celsius in a report on Thursday, June 26th. Finally, JPMorgan Chase & Co. boosted their price target on Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a report on Thursday, July 31st. Seventeen equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $59.89.

Celsius Stock Performance

Shares of CELH stock traded down $2.39 during midday trading on Tuesday, hitting $58.37. The company had a trading volume of 5,976,793 shares, compared to its average volume of 6,431,793. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. Celsius has a 52-week low of $21.10 and a 52-week high of $63.50. The stock has a market cap of $15.06 billion, a price-to-earnings ratio of 157.76, a PEG ratio of 1.38 and a beta of 1.34. The company's 50 day simple moving average is $51.32 and its 200 day simple moving average is $41.03.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The firm had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same period in the previous year, the business earned $0.28 earnings per share. The company's revenue for the quarter was up 83.9% compared to the same quarter last year. Research analysts anticipate that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Activity at Celsius

In other news, major shareholder William H. Milmoe sold 300,000 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $47.27, for a total transaction of $14,181,000.00. Following the completion of the transaction, the insider owned 18,017,770 shares of the company's stock, valued at $851,699,987.90. This represents a 1.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Paul H. Storey sold 7,500 shares of the company's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total transaction of $456,975.00. Following the transaction, the insider directly owned 37,550 shares of the company's stock, valued at approximately $2,287,921.50. This represents a 16.65% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,123,641 shares of company stock worth $52,998,580. Corporate insiders own 2.55% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Hantz Financial Services Inc. increased its stake in shares of Celsius by 1,476.0% during the 2nd quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock valued at $37,000 after acquiring an additional 738 shares during the last quarter. Westside Investment Management Inc. purchased a new position in shares of Celsius in the 1st quarter worth about $32,000. Summit Securities Group LLC acquired a new position in shares of Celsius in the 1st quarter valued at about $34,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Celsius by 255.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after purchasing an additional 750 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in Celsius by 244.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the company's stock worth $52,000 after purchasing an additional 794 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.